Noel Goddard

Vorstandsvorsitzender bei

Qunnect, Inc.

51 Jahre

99 Beziehungen

Consumer Services

Commercial Services

Health Technology

Profil

Noel L.
Goddard was the founder of Goddard Labs, Inc., founded in 2012, where the title held was Chief Executive Officer from 2012 to 2016.
The current job is Chief Executive Officer & Director at Qunnect, Inc. starting in 2020.
Former jobs include Director at Biolabs, Inc. from 2017 to 2018; Director at Hashlynx, Inc. from 2021 to 2022; Independent Director at Monogram Technologies, Inc.; Advisor at The Catalytic Impact Foundation, Inc. from 2019 to 2021; Advisor at M Corp.
from 2019 to 2021; Chief Technology Officer at Symbiotic Health, Inc. from 2015 to 2018; and Portfolio Manager at Accelerate Long Island (Venture Capital) from 2020 to 2022.
Education includes a doctorate from The Rockefeller University conferred in 2004, and undergraduate and graduate degrees from New York University conferred in 1996 and 1998 respectively.

Aktive Positionen von Noel Goddard

Unternehmen	Position	Beginn
Qunnect, Inc. Qunnect, Inc. Computer Processing HardwareElectronic Technology Develops quantum hardware parts	Vorstandsvorsitzender	01.05.2020

Alle aktiven Positionen von Noel Goddard

Ehemalige bekannte Positionen von Noel Goddard

Unternehmen	Position	Ende
Hashlynx, Inc. Hashlynx, Inc. Information Technology ServicesTechnology Services Operates as a block chain technology to trade and settle syndicated loan markets	Direktor/Vorstandsmitglied	31.01.2022
Accelerate Long Island (Venture Capital) Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for seed stage capital requirements. The firm makes follow-on investments.	Private Equity Investor	01.01.2022
M Corp. M Corp. Miscellaneous Commercial ServicesCommercial Services Provides information technology solutions and consulting services	Berater	31.12.2021
The Catalytic Impact Foundation, Inc. The Catalytic Impact Foundation, Inc. The Catalytic Impact Foundation, Inc. is a nonprofit venture philanthropy organization that accelerates innovation in life sciences and healthcare by investing philanthropic capital with venture discipline into early-stage companies addressing critical unmet medical needs. The private company is located in the US. The foundation bridges the funding gap between early research and commercialization to bring health technologies to patients, focusing on underfunded areas such as women’s health, children’s health, brain and mental health, rare diseases, health equity, and aging. It prioritizes scalable, accessible solutions for conditions that disproportionately affect or are poorly addressed in these populations and supports women-led companies through its women leaders in health innovation initiative. The foundation operates with a regenerative philanthropy model, using donated capital to make equity investments in promising life science companies and recycling returns to sustain and scale impact. Its portfolio includes companies developing diagnostics, drug delivery systems, and medical devices, and it also offers fiscal sponsorship to mission-aligned projects lacking nonprofit status.	Berater	31.01.2021
Symbiotic Health, Inc. Symbiotic Health, Inc. BiotechnologyHealth Technology Develops probiotic microbes that supports healthy aging	Technik-/Wissenschafts-/F&E-Leiter	30.04.2018

Sehen Sie sich die Erfahrung von Noel Goddard im Detail an

Ausbildung von Noel Goddard

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Noel Goddard im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	11
Biolabs, Inc. Biolabs, Inc. Medical/Nursing ServicesHealth Services Operates a healthcare laboratory	Health Services
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Rockefeller University The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
M Corp. M Corp. Miscellaneous Commercial ServicesCommercial Services Provides information technology solutions and consulting services	Commercial Services
Symbiotic Health, Inc. Symbiotic Health, Inc. BiotechnologyHealth Technology Develops probiotic microbes that supports healthy aging	Health Technology
Accelerate Long Island (Venture Capital) Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for seed stage capital requirements. The firm makes follow-on investments.	Finance
Monogram Orthopaedics, Inc. Monogram Orthopaedics, Inc. Medical SpecialtiesHealth Technology Develops robotics orthopedic devices	Health Technology
Hashlynx, Inc. Hashlynx, Inc. Information Technology ServicesTechnology Services Operates as a block chain technology to trade and settle syndicated loan markets	Technology Services
Goddard Labs, Inc. Goddard Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research and development company	Commercial Services
Qunnect, Inc. Qunnect, Inc. Computer Processing HardwareElectronic Technology Develops quantum hardware parts	Electronic Technology
The Catalytic Impact Foundation, Inc. The Catalytic Impact Foundation, Inc. The Catalytic Impact Foundation, Inc. is a nonprofit venture philanthropy organization that accelerates innovation in life sciences and healthcare by investing philanthropic capital with venture discipline into early-stage companies addressing critical unmet medical needs. The private company is located in the US. The foundation bridges the funding gap between early research and commercialization to bring health technologies to patients, focusing on underfunded areas such as women’s health, children’s health, brain and mental health, rare diseases, health equity, and aging. It prioritizes scalable, accessible solutions for conditions that disproportionately affect or are poorly addressed in these populations and supports women-led companies through its women leaders in health innovation initiative. The foundation operates with a regenerative philanthropy model, using donated capital to make equity investments in promising life science companies and recycling returns to sustain and scale impact. Its portfolio includes companies developing diagnostics, drug delivery systems, and medical devices, and it also offers fiscal sponsorship to mission-aligned projects lacking nonprofit status.